Back
ESC Premium Access

CSK9 inhibitors and cardiovascular outcomes – Represented in New England Journal of Medicine by the FOURIER and SPIRE trials.

Session: Highlights from the New England Journal of Medicine: editors’ choice
Topic: Miscellaneous
Speaker: Professor M. Sabatine (Boston, US)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Marc Sabatine

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
23 presentations
1 follower

3 more presentations in this session

Bioresorbable vascular scaffolds for PCI – Represented in New England Journal of Medicin by the ABSORB III and AIDA trials.

Speaker: Doctor J. Wykrzykowska (Amsterdam, NL)

Access
Slides
Video
Thumbnail

ICD implantation for non-ischaemic cardiomyopathy – Represented in New England Journal of Medicine by the DANISH trial.

Speaker: Professor L. Kober (Copenhagen, DK)

Access
Slides
Video
Thumbnail

Prevention of recurrent venous thromboembolism – Represented in New England Journal of Medicine by several trials, including EINSTEIN, AMPLIFY, WARFASA, Hokusai-VTE, and others.

Speaker: Doctor J. Weitz (Hamilton, CA)

Access
Slides
Video
Thumbnail

Access the full session

Highlights from the New England Journal of Medicine: editors’ choice

Speakers: Professor M. Sabatine, Doctor J. Wykrzykowska, Professor L. Kober, Doctor J. Weitz
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb